Supplementary Figure from Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist–Treated Prostate Cancers
Maxwell PJ., McKechnie M., Armstrong CW., Manley JM., Ong CW., Worthington J., Mills IG., Longley DB., Quigley JP., Zoubeidi A., de Bono JS., Deryugina E., LaBonte MJ., Waugh DJJ.
Supplementary Figure from Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist–Treated Prostate Cancers